Safety you can trust
MEPTIDE has been studied in extensive clinical programs. Review the common side effects, contraindications, warnings and precautions below. This information is not a substitute for professional medical advice.
What to expect, and what to do
Most common adverse events are generally mild to moderate and diminish over time.
Nausea
CommonMost common at treatment start; usually diminishes over time.
Vomiting
CommonMild to moderate in most cases; may occur early in treatment.
Diarrhea
CommonGastrointestinal side effects often lessen as treatment continues.
Constipation
CommonEnsure adequate hydration and fibre as recommended.
Dyspepsia
CommonIndigestion may occur; talk to your doctor if persistent.
Decreased appetite
CommonExpected effect supporting reduced caloric intake.
Injection-site reactions
CommonRotate injection sites to minimize local reactions.
When should you contact your doctor?
Persistent severe abdominal pain
Severe vomiting
Dehydration
Hypoglycemia when combined with insulin or sulfonylureas
Do not use MEPTIDE if you have any of the following
Hypersensitivity to Tirzepatide or any component of the formulation
Personal or family history of Medullary Thyroid Carcinoma (MTC)
Multiple Endocrine Neoplasia Syndrome Type 2 (MEN2)
Use cautiously in patients with the following
Pancreatitis — use caution in patients with a history of pancreatitis.
Severe gastrointestinal disease — monitor closely.
Diabetic retinopathy — monitor for changes.
Renal impairment — monitor hydration status.
Gallbladder disease — use with caution.
Hypoglycemia when combined with insulin or sulfonylureas — dose adjustment may be required.
Use caution with these medicines
Insulin
Sulfonylureas
Oral medicines requiring rapid gastrointestinal absorption
Dose adjustment of insulin or sulfonylureas may be required when used together.
Use in special populations
Renal Impairment
No routine dose adjustment is generally required; monitor hydration status.
Hepatic Impairment
No clinically meaningful dosage adjustment is generally required.
Elderly
No dose adjustment based solely on age.
Pregnancy, overdose & storage
Pregnancy & Lactation
- There are insufficient human data regarding use during pregnancy or breastfeeding.
- MEPTIDE should be used only if the potential benefit outweighs potential risk.
- Women planning pregnancy should discuss treatment options with their healthcare provider.
Overdosage
Symptoms may include severe nausea, vomiting, gastrointestinal discomfort, and hypoglycemia (particularly with concomitant insulin or sulfonylureas). Management is supportive and symptomatic.
Storage Conditions
- • Store refrigerated at 2°C–8°C
- • Do not freeze
- • Protect from direct light
- • Keep in original carton until use
- • Keep out of reach of children
Take the First Step Toward a Healthier Future
MEPTIDE is a prescription medicine. Talk to your doctor to determine whether Tirzepatide is appropriate for your glycemic control and weight-management goals.
Individual results vary. Always follow your healthcare provider's guidance.